IMPAIRED GENERAL CELL-MEDIATED IMMUNE FUNCTIONS INVIVO AND INVITRO IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA

[1] Boyum A., 1968, SCAND J CLIN LAB INV, V97, P7

[2] CHAN SH, 1976, P SOC EXP BIOL MED, V151, P716

[3] CHAN SH, 1975, LANCET, V1, P1246

[4] IMPAIRED IMMUNORESPONSIVENESS IN TUMOR PATIENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 230 (MAR18) : 56 - 85

[5] Herberman R B, 1974, Adv Cancer Res, V19, P207, DOI 10.1016/S0065-230X(08)60055-X

[6] SIMONS MJ, 1975, LANCET, V1, P142

[7] SIMONS MJ, 1976, 6TH P INT HIST WORKS

[8] SIMONS MJ, IN PRESS

[9] STJERNSWARD J, 1969, 4 PEN QUAD INT C CAN, P749

[10] TARPLEY JL, 1975, CANCER, V35, P638, DOI 10.1002/1097-0142(197503)35:3<638::AID-CNCR2820350315>3.0.CO

[1] Boyum A., 1968, SCAND J CLIN LAB INV, V97, P7

[2] CHAN SH, 1976, P SOC EXP BIOL MED, V151, P716

[3] CHAN SH, 1975, LANCET, V1, P1246

[4] IMPAIRED IMMUNORESPONSIVENESS IN TUMOR PATIENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 230 (MAR18) : 56 - 85

[5] Herberman R B, 1974, Adv Cancer Res, V19, P207, DOI 10.1016/S0065-230X(08)60055-X

[6] SIMONS MJ, 1975, LANCET, V1, P142

[7] SIMONS MJ, 1976, 6TH P INT HIST WORKS

[8] SIMONS MJ, IN PRESS

[9] STJERNSWARD J, 1969, 4 PEN QUAD INT C CAN, P749

[10] TARPLEY JL, 1975, CANCER, V35, P638, DOI 10.1002/1097-0142(197503)35:3<638::AID-CNCR2820350315>3.0.CO